{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:43:54Z","timestamp":1710377034967},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00228-024-03622-8","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T02:04:05Z","timestamp":1705975445000},"page":"545-552","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular medications used for comorbid diseases in patients with atrial fibrillation. The JoFib study"],"prefix":"10.1007","volume":"80","author":[{"given":"Nasr","family":"Alrabadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al-Nusair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razan","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lama","family":"Alburie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizar","family":"Mhaidat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Aljarrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Hamoudeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"3622_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","volume":"127","author":"J Kornej","year":"2020","unstructured":"Kornej J, B\u00f6rschel CS, Benjamin EJ, Schnabel RB (2020) Epidemiology of Atrial Fibrillation in the 21st Century. Circ Res 127:4\u201320. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316340","journal-title":"Circ Res"},{"key":"3622_CR2","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI et al (2023) Heart Disease and Stroke Statistics\u20142023 update: a Report from the American Heart Association. Circulation 147:e93\u2013e621. https:\/\/doi.org\/10.1161\/CIR.0000000000001123","journal-title":"Circulation"},{"key":"3622_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H et al (2019) 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines and the heart R. J Am Coll Cardiol 74:104\u2013132.https:\/\/doi.org\/10.1016\/j.jacc.2019.01.011","journal-title":"J Am Coll Cardiol"},{"key":"3622_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00392-023-02179-3","volume":"112","author":"CS Park","year":"2023","unstructured":"Park CS, Kim B, Rhee T-M et al (2023) Association between renin\u2013angiotensin\u2013aldosterone system blockade and clinical outcomes in patients with hypertension: real-world observation from a nationwide hypertension cohort. Clin Res Cardiol 112:1577\u20131586. https:\/\/doi.org\/10.1007\/s00392-023-02179-3","journal-title":"Clin Res Cardiol"},{"key":"3622_CR5","doi-asserted-by":"crossref","unstructured":"Yu Z, Zhang D, Ji Q, Yi F (2021) Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation: an overview of systematic reviews. Med (Baltim) 100","DOI":"10.1097\/MD.0000000000025559"},{"key":"3622_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4022\/jafib.608","volume":"5","author":"M Imazio","year":"2012","unstructured":"Imazio M (2012) Primary Prevention of Atrial Fibrillation where are we in 2012? J Atr Fibrillation 5:608.https:\/\/doi.org\/10.4022\/jafib.608","journal-title":"J Atr Fibrillation"},{"key":"3622_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10741-019-09837-7","volume":"25","author":"A Mascolo","year":"2020","unstructured":"Mascolo A, Urbanek K, De Angelis A et al (2020) Angiotensin II and angiotensin 1\u20137: which is their role in atrial fibrillation? Heart Fail Rev 25:367\u2013380. https:\/\/doi.org\/10.1007\/s10741-019-09837-7","journal-title":"Heart Fail Rev"},{"key":"3622_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/EURHEARTJ\/EHAA612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42:373\u2013498. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAA612","journal-title":"Eur Heart J"},{"key":"3622_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.repc.2020.11.010","volume":"40","author":"A Oraii","year":"2021","unstructured":"Oraii A, Vasheghani-Farahani A, Oraii S et al (2021) Update on the efficacy of statins in primary and secondary prevention of atrial fibrillation. Rev Port Cardiol 40:509\u2013518. https:\/\/doi.org\/10.1016\/j.repc.2020.11.010","journal-title":"Rev Port Cardiol"},{"key":"3622_CR10","doi-asserted-by":"publisher","unstructured":"Hammoudeh AJ, Khader Y, Kadri N et al (2021) Adherence to the 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline on the use of oral anticoagulant agents in Middle Eastern patients with Atrial Fibrillation: the Jordan Atrial Fibrillation (JoFib) Study. Int J Vasc Med 2021(5515089). https:\/\/doi.org\/10.1155\/2021\/5515089","DOI":"10.1155\/2021\/5515089"},{"key":"3622_CR11","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the management of Heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation 145:e895\u2013e1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"3622_CR12","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J 44:3720\u20133826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"3622_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12872-022-02580-2","volume":"22","author":"W Xu","year":"2022","unstructured":"Xu W, Yang Y, Zhu J et al (2022) Impact of renin\u2013angiotensin\u2013aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension. BMC Cardiovasc Disord 22:141. https:\/\/doi.org\/10.1186\/s12872-022-02580-2","journal-title":"BMC Cardiovasc Disord"},{"key":"3622_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","volume":"45","author":"K Wachtell","year":"2005","unstructured":"Wachtell K, Lehto M, Gerdts E et al (2005) Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol 45:712\u2013719. https:\/\/doi.org\/10.1016\/j.jacc.2004.10.068","journal-title":"J Am Coll Cardiol"},{"key":"3622_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejim.2023.08.019","volume":"119","author":"D Menichelli","year":"2024","unstructured":"Menichelli D, Poli D, Antonucci E et al (2024) Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry. Eur J Intern Med 119:84\u201392. https:\/\/doi.org\/10.1016\/j.ejim.2023.08.019","journal-title":"Eur J Intern Med"},{"key":"3622_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2796.2007.01780.x","volume":"261","author":"GYH Lip","year":"2007","unstructured":"Lip GYH, Frison L, Grind M, Committee on B of the SI and the SES (2007) Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation. J Intern Med 261:577\u2013586. https:\/\/doi.org\/10.1111\/j.1365-2796.2007.01780.x","journal-title":"J Intern Med"},{"key":"3622_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1474-4422(09]70058-4","volume":"8","author":"P Amarenco","year":"2009","unstructured":"Amarenco P, Labreuche J (2009) Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 8:453\u2013463. https:\/\/doi.org\/10.1016\/S1474-4422(09]70058-4","journal-title":"Lancet Neurol"},{"key":"3622_CR18","doi-asserted-by":"publisher","unstructured":"Choi KH, Seo WK, Park MS et al (2019) Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation. J Am Heart Assoc. 2019;8[24]:e013941. EpubDec 12:. https:\/\/doi.org\/10.1161\/JAHA.119.013941","DOI":"10.1161\/JAHA.119.013941"},{"key":"3622_CR19","doi-asserted-by":"publisher","first-page":"105418","DOI":"10.1016\/j.phrs.2021.105418","volume":"165","author":"D Pastori","year":"2021","unstructured":"Pastori D, Baratta F, Di Rocco A et al (2021) Statin use and mortality in atrial fibrillation: a systematic review and meta-analysis of 100,287 patients. Pharmacol Res 165:105418. https:\/\/doi.org\/10.1016\/j.phrs.2021.105418","journal-title":"Pharmacol Res"},{"key":"3622_CR20","doi-asserted-by":"publisher","unstructured":"Goldstein LB, Amarenco P, Szarek M et al (2008) Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 70:2364 LP \u2013 2370. https:\/\/doi.org\/10.1212\/01.wnl.0000296277.63350.77","DOI":"10.1212\/01.wnl.0000296277.63350.77"},{"key":"3622_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijcard.2017.08.055","volume":"248","author":"M Proietti","year":"2017","unstructured":"Proietti M, Laroche C, Nyvad O et al (2017) Use of statins and adverse outcomes in patients with atrial fibrillation: an analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase. Int J Cardiol 248:166\u2013172. https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.055","journal-title":"Int J Cardiol"},{"key":"3622_CR22","doi-asserted-by":"publisher","first-page":"i4482","DOI":"10.1136\/bmj.i4482","volume":"354","author":"A Odutayo","year":"2016","unstructured":"Odutayo A, Wong CX, Hsiao AJ et al (2016) Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 354:i4482. https:\/\/doi.org\/10.1136\/bmj.i4482","journal-title":"BMJ"},{"key":"3622_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12916-021-02048-8","volume":"19","author":"R Zakeri","year":"2021","unstructured":"Zakeri R, Morgan AD, Sundaram V et al (2021) Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study. BMC Med 19:179. https:\/\/doi.org\/10.1186\/s12916-021-02048-8","journal-title":"BMC Med"},{"key":"3622_CR24","doi-asserted-by":"publisher","unstructured":"Shengbo Y (2011) Diuretics administration correlate with atrial fibrillation in patients with chronic systolic heart failure. Heart 97.https:\/\/doi.org\/10.1136\/heartjnl-2011-300867.625. A213 LP-A213","DOI":"10.1136\/heartjnl-2011-300867.625"},{"key":"3622_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jacc.2014.07.957","volume":"64","author":"M Hamon","year":"2014","unstructured":"Hamon M, Lemesle G, Tricot O et al (2014) Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease. J Am Coll Cardiol 64:1430\u20131436. https:\/\/doi.org\/10.1016\/j.jacc.2014.07.957","journal-title":"J Am Coll Cardiol"},{"key":"3622_CR26","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","volume":"129","author":"M Lamberts","year":"2014","unstructured":"Lamberts M, Gislason GH, Lip GYH et al (2014) Antiplatelet Therapy for stable coronary artery disease in Atrial Fibrillation patients taking an oral anticoagulant. Circulation 129:1577\u20131585. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.004834","journal-title":"Circulation"},{"key":"3622_CR27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/clc.22750","volume":"40","author":"G Lemesle","year":"2017","unstructured":"Lemesle G, Ducrocq G, Elbez Y et al (2017) Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events. Clin Cardiol 40:932\u2013939. https:\/\/doi.org\/10.1002\/clc.22750","journal-title":"Clin Cardiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03622-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03622-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03622-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T08:34:19Z","timestamp":1710318859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03622-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3622"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03622-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"3 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board (IRB) of participating centers (16072019151). The study was registered with Clinicaltrials.gov (unique identifier number: NCT03917992).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}